Options VI Conference Sponsors

	Sponsors The Organizing Committee would like to recognize the following organizations for their support of the *Options VI* conference and for their dedication to the prevention, control, and treatment of influenza. The Organizing Committee invites organizations to support the Options for the Control of Influenza VI conference, June 17-23, 2007, in Toronto, Ontario, Canada. Unparalleled corporate visibility is provided by the unique opportunities offered in conjunction with this triennial meeting. To maintain a fair, balanced, and independent conference, the Organizing Committee in collaboration with the Center for Accredited Healthcare Education (CAHE) will have final authority to approve all industry-supported activities at the Options VI conference. Commercial organizations interested in supporting the Options VI conference can choose from any of the opportunities described in the Support Opportunities brochure. If you would like to organize additional events on or around the conference please contact the conference secretariat. All suggested activities are subject to approval by the Organizing Committee.
		Download Support Opportunities Brochure
	Commercial Symposium Guidelines Promotional activities during the *Options for the Control of Influenza VI* conference must be consistent with high ethical standards, and information should be designed to help healthcare providers improve services to patients. Information must be provided with objectivity, truthfulness, and in good taste and must conform to all relevant laws and regulations. Canada's Rx&D Code of Conduct Canada's Research-Based Pharmaceutical Companies (Rx&D) is the national association representing over 22,000 men and women who work for more than 50 research-based pharmaceutical companies in Canada. In recognition of its role in the international pharmaceutical community, Rx&D is a member of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA). http://www.ifpma.org/News/news_market.aspx The IFPMA is a nongovernmental organization representing pharmaceutical associations in 51 countries around the world. Part of its mission is: “To promote and support continuous development, throughout the pharmaceutical industry, of ethical principles and practices voluntarily agreed on...” As a member of the IFPMA, Rx&D strongly supports IFPMA's mission and the principles of its Code of Pharmaceutical Marketing Practices. Canada is recognized as having strict regulations in the pharmaceutical industry. All pharmaceutical companies must adhere to Rx&D's Code of Conduct. If a pharmaceutical company is conducting business in Canada, it is their responsibility to educate themselves and adhere to the Canadian Industry standards. The entire Rx&D Code of Conduct can be found on their website, along with examples of service-oriented items that have been accepted and rejected under this code. It is the pharmaceutical company's responsibility to adhere to all guidelines. Please click on the link below for a PDF of the guiding principles: http://www.canadapharma.org/Industry_Publications/Code/GuidingPrinciples0512.pdf. We recommend that all exhibitors, whether they are conducting a CME or Commercial symposium, review the information regarding the Rx&D Code of Conduct. For more information please visit Canada's Research-Based Pharmaceutical Companies website http://www.canadapharma.org. The Options for the Control of Influenza VI, Conference Chair, Organizing Committee, Scientific Committee, and Official Secretariat will cooperate with Canada's Rx&D to ensure the enforcement of their guidelines and is not responsible for noncompliance to the Code of Conduct.

	Conference Secretariat MediTech Media Conferencing, Inc. Six Concourse Parkway Suite 3000 Atlanta, GA 30328 Toll Free: 866 686 8732 (US) Phone: +1 404 233 6446 Fax: +1 404 233 2827